These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 5160902)
1. Screening of the cytotoxic action of fungus filtrates on Ehrlich's ascites carcinoma, utilizing 14 C-labelled precursors. Fuska J; Miko M; Nemec P; Drobnica L Neoplasma; 1971; 18(6):631-6. PubMed ID: 5160902 [No Abstract] [Full Text] [Related]
2. Cytotoxicity and mode of action of the potential cytostatic drug oracin. Miko M; Poturnajova M; Soucek R Neoplasma; 2002; 49(3):167-71. PubMed ID: 12098002 [TBL] [Abstract][Full Text] [Related]
3. In vitro effect of alpha, beta-unsaturated sulphones of the 5-nitrofuran series on the incorporation of C-labelled precursors into Ehrlich's ascites carcinoma cells. Fuska J; Fusková A; Jurásek A Acta Biol Med Ger; 1978; 37(2):199-204. PubMed ID: 568367 [TBL] [Abstract][Full Text] [Related]
4. 9-Hydroxybenfluron: cytostatic effects and inhibition of macromolecular biosynthesis in Ehrlich ascites and P388 murine leukemia cells. Miko M; Krepelka J; Melka M Anticancer Drugs; 1991 Jun; 2(3):289-95. PubMed ID: 1802025 [TBL] [Abstract][Full Text] [Related]
5. Comparative investigation of the effect of ukrain on growth of ascites and solid forms of Ehrlich's carcinoma. Susak YM; Skivka LM; Rudik MP; Pozur VV; Liubunya AV Exp Oncol; 2010 Jul; 32(2):107-10. PubMed ID: 20693973 [TBL] [Abstract][Full Text] [Related]
6. Metabolic activity of the Ehrlich ascites carcinoma cells and the significance of ascites serum addition. Miko M; Drobnica L Neoplasma; 1969; 16(2):161-9. PubMed ID: 5822918 [No Abstract] [Full Text] [Related]
7. [The use of labelled cells and chemical compounds for the analysis of the mechanism of action of cytotoxic substances]. Lettré H Nucl Med (Stuttg); 1965; 2():3-16. PubMed ID: 5888973 [No Abstract] [Full Text] [Related]
8. The cytotoxic action of granaticin, a sulfhydryl-reactive antibiotic, on Ehrlich ascites carcinoma cells. Sturdík E; Drobnica L Neoplasma; 1983; 30(1):3-6. PubMed ID: 6835436 [No Abstract] [Full Text] [Related]
9. In vitro cytotoxicity and mode of action of 1-alkylpyrrolidine N-oxides. Miko M; Devinsky F Neoplasma; 1993; 40(3):153-9. PubMed ID: 8350962 [TBL] [Abstract][Full Text] [Related]
10. Effect of 3'-amino-3'-deoxyadenosine on nucleic acid synthesis in Ehrlich ascites tumor cells. Truman JT; Klenow H Mol Pharmacol; 1968 Jan; 4(1):77-86. PubMed ID: 5640781 [No Abstract] [Full Text] [Related]
11. The primary cultures of animal ascites tumor cells growth in tubes in suspension as a model in the screening of antitumor agents. Ivanitskaya LP; Makukho LV Neoplasma; 1975; 22(1):105-7. PubMed ID: 1153034 [TBL] [Abstract][Full Text] [Related]
12. Biochemical effects of formycin, an adenosine analog. Henderson JF; Paterson AR; Caldwell IC; Hori M Cancer Res; 1967 Apr; 27(4):715-9. PubMed ID: 4290625 [No Abstract] [Full Text] [Related]
13. [Effect of mouse interferons on the development of Ehrlich ascitic carcinoma]. Solov'ev VD; Krispin TI; Balandin IG Biull Eksp Biol Med; 1980 Mar; 89(3):330-2. PubMed ID: 6155950 [TBL] [Abstract][Full Text] [Related]
14. Metabolic activity of the Ehrlich ascites cells in synthetic media and the significance of ascites serum addition. Miko M; Drobnica L Neoplasma; 1972; 19(3):163-73. PubMed ID: 5047461 [No Abstract] [Full Text] [Related]
15. Cytotoxic and cancerostatic effect of 1,4-dithiaanthraquinone-2,3-dicarbonitrile. Drobnica L; Sturdík E; Horáková K; Miko M Neoplasma; 1978; 25(5):577-84. PubMed ID: 740057 [TBL] [Abstract][Full Text] [Related]
16. [The studies on anerobic glycolysis and the inhibition of lactic acid production in Ehrlich's ascites carcinoma by anticancer agents]. Koga H Kumamoto Igakkai Zasshi; 1971 Feb; 45(2):169-99. PubMed ID: 5109085 [No Abstract] [Full Text] [Related]